Ryan Dregalla,Leonard R. Duford,Dean Nistal,Tracee Gruber
申请号：
US16043520
公开号：
US20180325962A1
申请日:
2018.07.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. The product may include various scaffolding such as biomaterials or human tissue, and the scaffolding may be infused with various plasmas and agents. The cell-free treatment may maintain the biological activity of many therapeutic agents found within cells and may possess multiple structural components to support cellular attachment. The structural components or scaffolds may function as a reservoir of highly diffusible chemotactic and cellular-programming factors that may be useful to treat injury and disease.
